Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
McKinsey
Merck
Express Scripts
Harvard Business School

Last Updated: June 28, 2022

Eywa Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for EYWA, and what generic and branded alternatives to EYWA drugs are available?

EYWA has sixteen approved drugs.



Summary for Eywa
US Patents:0
Tradenames:15
Ingredients:15
NDAs:16

Drugs and US Patents for Eywa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eywa Pharma ACETAZOLAMIDE acetazolamide TABLET;ORAL 211556-001 Oct 18, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
Eywa Pharma ALOSETRON HYDROCHLORIDE alosetron hydrochloride TABLET;ORAL 211621-001 Sep 16, 2019 DISCN No No See Plans and Pricing See Plans and Pricing
Eywa OXYBUTYNIN CHLORIDE oxybutynin chloride TABLET;ORAL 211062-001 Feb 6, 2019 BX RX No No See Plans and Pricing See Plans and Pricing
Eywa POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 214426-002 Feb 19, 2021 AB RX No No See Plans and Pricing See Plans and Pricing
Eywa LABETALOL HYDROCHLORIDE labetalol hydrochloride TABLET;ORAL 207863-002 Feb 4, 2019 AB RX No No See Plans and Pricing See Plans and Pricing
Eywa METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride SOLUTION;ORAL 210139-002 Oct 3, 2018 AA RX No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Colorcon
Johnson and Johnson
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.